{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:10:06Z","timestamp":1783818606584,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ijantimicag.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T04:20:16Z","timestamp":1299558016000},"page":"472-475","source":"Crossref","is-referenced-by-count":23,"title":["Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood"],"prefix":"10.1016","volume":"37","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Bosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1542\/peds.2007-0240","article-title":"Pediatric encephalitis: what is the role of Mycoplasma pneumoniae?","volume":"120","author":"Christie","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jinf.2005.07.005","article-title":"Central nervous system manifestations of Mycoplasma pneumoniae infections","volume":"51","author":"Tsiodras","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1086\/320748","article-title":"Acute childhood encephalitis and Mycoplasma pneumonia","volume":"32","author":"Bitnum","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/spid.2003.127226","article-title":"Mycoplasma pneumoniae encephalitis","volume":"14","author":"Bitnum","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0030","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1073\/pnas.0510644103","article-title":"ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens","volume":"103","author":"Kannan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumonia and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1473-3099(01)00147-5","article-title":"Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections","volume":"1","author":"Principi","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dkp160","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis","volume":"64","author":"Peuchant","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/INF.0b013e31819e3f7a","article-title":"Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates","volume":"28","author":"Li","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0055","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood\u2013cerebrospinal fluid\/blood\u2013brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/INF.0b013e3180cc20e4","article-title":"Will fluoroquinolones ever be recommended for common infections in children?","volume":"26","author":"Schaad","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/505120","article-title":"Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy","volume":"43","author":"Esposito","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/dkg365","article-title":"Bactericidal activity of levofloxacin against Mycoplasma pneumonia","volume":"52","author":"Duffy","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.01.008_bib0075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.40.3.825","article-title":"Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye","volume":"40","author":"Jaruratanasirikul","year":"1996","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T04:12:05Z","timestamp":1560053525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0924857911000574"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.01.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}